DBV Technologies S.A.·4

Nov 25, 5:13 PM ET

Mohideen Pharis 4

4 · DBV Technologies S.A. · Filed Nov 25, 2024

Insider Transaction Report

Form 4
Period: 2024-11-21
Mohideen Pharis
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-11-21+215,000215,000 total
    Exercise: $0.75Exp: 2034-11-21Ordinary Shares (215,000 underlying)
  • Award

    Ordinary Shares

    2024-11-21+35,000114,367 total
  • Sale

    Ordinary Shares

    2024-11-21$0.54/sh2,350$1,269112,017 total
Footnotes (5)
  • [F1]The ordinary shares may be represented by American Depositary Shares, each of which currently represents one ordinary share.
  • [F2]Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2025, subject to the Reporting Person continuing to provide service through each such date.
  • [F3]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
  • [F4]This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0546 to EURO 1.00 as of November 21, 2024.
  • [F5]The option shall vest in four equal annual installments commencing on November 21, 2025, subject to the Reporting Person continuing to provide service through each such date.

Documents

1 file
  • 4
    form4-11252024_101142.xmlPrimary